Laurus Labs Limited — Board/Management Information 2024

Oct 3, 2024

==> picture [191 x 81] intentionally omitted <==

Date: October 03, 2024

To The Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Code: 540222	To The Listing Department National Stock Exchange of India Ltd., Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Code: LAURUSLABS

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you that the Members of the Company by way of Postal ballot through e-voting with the requisite majority have approved today the appointment of Mr. Ramesh Subrahmanian (DIN: 02933019) as a Non-executive Independent Director of the Company. It may be noted that Mr. Ramesh Subrahmanian was appointed as an Additional Director of the Company on 25[th] July, 2024, for the term of five years with effect from July 25, 2024.

We hereby confirm that Mr. Ramesh Subrahmanian meets the criteria for independence as required under Section 149(6) of the Companies Act, 2013 and the rules made thereunder and Regulation 16(1)(b) of the Listing Regulations and that he is not debarred from holding the office of director by virtue of any order of SEBI or any other such authority.

The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is annexed herewith.

Kindly take the same on your records.

Yours faithfully,

For Laurus Labs Limited

VENKATESWAR Digitally signed by VENKATESWAR REDDY REDDY GOGIREDDY GOGIREDDY Date: 2024.10.03 19:19:06 +05'30'

G. Venkateswar Reddy

Company Secretary & Compliance Officer

Encl: A/a

==> picture [452 x 76] intentionally omitted <==

Annexure

==> picture [191 x 81] intentionally omitted <==

Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

- Appointment of Mr. Ramesh Subrahmanian as a Non executive Independent Director of the Company

a.	Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise	Approval of members for appointment of Mr. Ramesh Subrahmanian (DIN: 02933019) as an Independent Director, who was appointed as additional director in categoryof Independent Director on July25,2024.
b.	Date of appointment/re- appointment/cessation (as applicable) & term of appointment/re-appointment	Appointment is effective from July 25, 2024, for a tenure of 5 years.
c.	Brief Profile (in case of appointment)	Mr. Ramesh Subrahmanian (DIN: 02933019) (63 Years) holds a bachelor’s degree in Commerce from the University of Mumbai. He is also a certified Chartered Accountant from the Institute of Chartered Accountants in England & Wales. He has about 32 years of experience in pharmaceuticals, medical devices and speciality chemicals including immense years of experience with Sanofi and its predecessor companies (Aventis, HMR and Hoechst AG). He is also the founder and director of Alchemy Advisors, an advisory firm based in Singapore.
d.	Disclosure of relationships between directors (in case of appointment of a director)	Mr. Ramesh Subrahmanian is not related to any Director of the Company.

==> picture [452 x 76] intentionally omitted <==